Ocular Therapeutix Inc. (OCUL)
Market Closed
16 Oct, 08:00 PM
$
6. 87
-0.51
-6.9106%
$
1.62B Market Cap
- P/E Ratio
- Div Yield
2.76M Volume
-1.05 Eps
$ 7.38
Previous Close 
Want to track OCUL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ocular Therapeutix Inc. (OCUL) Statistics
Valuation metrics
Market Cap 1.62B
Enterprise value 1.13B
Trailing P/E (ttm) -5.31
Forward P/E -5.39
PEG ratio 0.47
Price/Sales (ttm) 31.72
Price/Book (mrq) 3.26
Enterprise Value/Revenue 21.74
Enterprise Value/EBITDA -3.98
Overview
Shares outstanding 218.9M
Float 184.63M
Shares short 24.79M
% Held by insiders 0.01%
% Held by institutions 0.96%
Average volume (10 days) 2.63M
Average volume (90 days) 1.99M
Price summary
52-Week low 6.23
52-Week high 16.44
Beta 0.93
50-Day moving average 9.97
200-Day moving average 9.01
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -5.79%
Operating margin -6.03%
Operational effectiveness
Return on assets -0.45%
Return on equity -0.6%
Income Statement
Revenue (ttm) 52.04M
Revenue per share (ttm) 0.23
Quarterly revenue growth (yoy) 0.01%
Gross profit (ttm) -175.06M
EBITDA -294.82M
Net income to common (ttm) -290.5M
Diluted EPS (ttm) -1.34
Quarterly earnings growth (yoy) 0.01%
Balance Sheet
Total cash (mrq) 666.7M
Total cash per share (mrq) 2.66
Total debt (mrq) 79.46M
Total Debt/Equity (mrq) 0.15
Current ratio (mrq) 13.11%
Book value per share (mrq) 2.31
Cash Flow
Cash flow statement -226.2M
Levered free cash flow (LFCF) -148.76M
2026 © Marketlog. All Rights Reserved.
